Harrow Inc
F:3IP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Harrow Inc (3IP) under the Base Case is 102.212 EUR per share.
Compared with the current market price of 75.328 EUR, the stock appears
Undervalued by 26% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Harrow Does
Harrow Health is an eye-care pharmaceutical company. It makes and sells prescription medicines and related products used by ophthalmologists, eye surgeons, and other eye-care providers, including branded drugs and compounded eye medications. Its products are meant for conditions around the eye and for use in clinics, surgery centers, and pharmacies that serve patients with vision-related needs.
- Headquarters
- United States of America US
- Employees
- 373
- IPO date
- Feb 8, 2013
Harrow has a narrow economic moat
Harrow Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Harrow Inc
Earnings Waterfall
Harrow Inc
What is the Intrinsic Value of one 3IP stock?
The intrinsic value for Harrow Inc (3IP) under the Base Case is 102.212 EUR.
Is 3IP stock undervalued or overvalued?
Compared with the current market price of 75.328 EUR, the stock appears Undervalued by 26% .
